Oral medicine for treating cyclomastopathy and production method
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technique for mammary gland hyperplasia and production methods, applied in the direction of medical formulas, drug combinations, and medical preparations with non-active ingredients, etc., can solve problems such as endocrine dysfunction, inaccurate curative effect, and difficulty in patients, and achieve low recurrence rate and effective treatment Thorough and high cure rate effect
Inactive Publication Date: 2017-04-26
XINJIANG MEDICAL UNIV
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] The treatment of western medicine to hyperplasia of mammary glands is just to distinguish its disease. Because the cause of disease is the disorder of sex hormones, hormone preparations such as tamoxifen are often used. The function is more disordered, so some people advocate local surgical resection of the lesion, but it often damages or sacrifices the breast unnecessarily, and it is not easy for patients to accept
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0030] Take 75 parts of combined medicament powder, add 5 parts of starch, 8% starch slurry, 12.5 parts of dry starch, and 0.4 part of magnesium stearate; mix the fine powder of medicine with starch, add starch slurry to make a soft material, and use a 14-mesh sieve Granulate, dry at 70°C, sieve through a 12-mesh sieve, add dry starch and magnesium stearate, mix, and press into tablets to obtain tablets.
Embodiment 2
[0032] Take 75 parts of the combined drug powder, add 5 parts of starch, 10 parts of 10% starch slurry; mix the drug fine powder with starch, add starch slurry to make a soft material, granulate with a 14-mesh sieve, dry at 70°C and then granulate at 12-mesh The granules are sieved to make granules, mixed evenly, and packed into gelatin capsules to obtain capsules.
Embodiment 3
[0034] Take 67 parts of the combined drug powder, add 12 parts of starch, 8 parts of 10% starch slurry, and 10 parts of dry starch; mix the drug fine powder with starch, add starch slurry to make a soft material, granulate with a 14-mesh sieve, and place at 70°C After drying, the granules are sieved with a 12-mesh sieve and packaged to obtain granules.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses an oral medicine for treating cyclomastopathy and a production method. The oral medicine for treating cyclomastopathy consists of the following components in parts by weight: 30-50 parts of bungarus parvus, 100-60 parts of pepper, 30-40 parts of gallnut, 20-30 parts of cuttle bone, 20-30 parts of catechu, 30-50 parts of root of Anacyclus pyrethrum(L)DC, 30-50 parts of radix curcumae longae, 30-40 parts of green cardamom, 10-50 parts of dracocephalum moldavuca linn, 20-60 parts of peganalaum harmala, 30-50 parts of lavender, 10-50 parts of scorpio (processed by virtue of a refining process), 20-60 parts of flos rosae rugosae, 20-60 parts of fructus chebulae, 20-60 parts of emblic leafflower fruit and 20-60 parts of Chinese dodder herb. The oral medicinal preparation for treating the cyclomastopathy has functions of promoting generation of dryness and heat, eliminating dampness and dispersing wind, relieving retardation, eliminating dampness and reducing phlegm, nourishing nerves, pleasing spirit and heart, calming heart and tranquilizing, inducing diuresis and dredging meridians, enhancing natural force of liver, eliminating retention and softening hard mass of mammary tissues. The oral medicine can be used for treating the cyclomastopathy caused by abnormal phlegm, abnormal savda and wild force.
Description
technical field [0001] The invention belongs to the field of medicine and health care products, and relates to an oral medicine for treating mammary gland hyperplasia and a production method. Background technique [0002] Mammary gland hyperplasia is a general term for a group of diseases whose main pathological changes are hyperplasia of mammary acini, ductal epithelial cells and connective tissue. It is clinically characterized by breast pain and lumps, and the severity changes with menstrual cycle and emotional changes. It is more common in middle-aged women aged 30 to 50, accounting for 75% of all breast diseases and ranking first among various breast diseases. Cancer may occur in the continuous and gradual evolution process. In the past 10 years, with the change of living environment, the incidence of mammary gland hyperplasia has gradually increased and tended to be younger, so that the incidence of breast cancer has also increased day by day. Therefore, the World Heal...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more